Investor List:

Top Pharmaceuticals Seed Investors in Washington, D.C. (48)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Kavita Patel, Venture Partner at New Enterprise Associates (NEA)
Kavita Patel
Sweet spot: $25.0M
Range: $2.0M - $50.0M
Investors in Washington (DC)
Photo of Scott Gottlieb, Partner at New Enterprise Associates (NEA)
Scott Gottlieb
Sweet spot: $25.0M
Range: $2.0M - $50.0M
Investors in Washington (DC)
Photo of Paul Newsom, Managing Director at VentureSouth
Paul Newsom
VentureSouth·Managing Director
Sweet spot: $10K
Range: $5K - $20K
Investors in Richmond (VA), Investors in Greenville (SC)
Investors in Pharmaceuticals (Seed), Investors in Space (Series A), Investors in Space (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in Enterprise Applications (Series A), Investors in Enterprise Applications (Seed), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Enterprise (Series A), Investors in Enterprise (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed), Investors in Medical Devices (Series A), Investors in Space (Series A), Investors in Medical Devices (Seed), Investors in Space (Seed), Investors in Pharmaceuticals (Seed), Investors in Enterprise Applications (Series A), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists), Investors in Enterprise Applications (Seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Enterprise (Series A), Investors in FinTech (Series A), Investors in Enterprise (Seed), Investors in FinTech (Seed)
Photo of Paul Clark, Managing Director at VentureSouth
Paul Clark
VentureSouth·Managing Director
Sweet spot: $10K
Range: $5K - $20K
Investors in Greenville (SC), Investors in Richmond (VA)
Investors in Space (Series A), Investors in Pharmaceuticals (Seed), Investors in Enterprise Applications (Seed), Investors in Space (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in Enterprise Applications (Series A), Investors in Digital Health (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Health IT (Series A), Investors in SaaS (Series A), Investors in Enterprise (Seed), Investors in SaaS (Seed), Investors in Enterprise (Series A), Investors in Space (Series A), Investors in Medical Devices (Seed), Investors in Space (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in Enterprise Applications (Series A), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists), Investors in Enterprise Applications (Seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in SaaS (Series A), Investors in Enterprise (Series A), Investors in SaaS (Seed), Investors in Enterprise (Seed)
Photo of Amy Kruse, General Partner at Prime Movers Lab
Amy Kruse
Prime Movers Lab·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Washington (D.C.)
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in AgTech (Series A), Investors in AgTech (Seed), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Enterprise (Series A), Investors in Washington, D.C. (Other Lists), Investors in BioTech (Seed), Investors in AI (Seed), Investors in Enterprise (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in AgTech (Seed), Investors in AgTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in AI (Series A), Investors in AI (Seed), Investors in Enterprise (Series A), Investors in Enterprise (Seed)
Photo of Harry Glorikian, General Partner at New Ventures Funds
Harry Glorikian
New Ventures Funds·General Partner
Sweet spot: $0
Range: $0 - $0
Investors in United States, Investors in Virginia Beach (VA), Investors in Boston (MA)
Photo of Tom V. Brooks, General Partner at Catalio Capital
Tom V. Brooks
Catalio Capital·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Denver (CO), Investors in Baltimore (MD)
Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in EnergyTech (Series A), Investors in EnergyTech (Series A), Investors in BioTech (Series A), Investors in EnergyTech (Seed), Investors in EnergyTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in EnergyTech (Series A), Investors in Colorado / Utah (Other Lists), Investors in EnergyTech (Seed), Investors in Washington, D.C. (Other Lists), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed)
Photo of Gregg L. Semenza, Venture Partner at Catalio Capital
Gregg L. Semenza
Catalio Capital·Venture Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD)
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Digital Health (Series A), Investors in Washington, D.C. (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed)